<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

qz

2025-07-16

Knockoff weight loss drugs were supposed to be 'gone and illegal'. Now they're bigger than ever

Compounding pharmacies that pharma giants thought they had defeated when the FDA banned copycat weight loss drugs are using a legal loophole to keep going [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination

2025-02-28

Engadget Podcast: iPhone 16e review and Amazon's AI-powered Alexa+

The keyword for the iPhone 16e seems to be "compromise." In this episode, Devindra chats with Cherlynn about her iPhone 16e review and try to figure out who this phone is actually for. Also, [...]

Match Score: 136.97

Destination

2025-01-03

The best smart scales for 2025

The New Year is here and there’s no better time to kickstart those health and fitness goals. Whether you’re looking to shed a few holiday pounds, track your muscle gains or simply stay on top of a [...]

Match Score: 117.13

thenextweb

2025-01-10

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 94.43

Destination

2025-02-13

Sony is actually remastering Days Gone before Bloodborne

Sony is giving Days Gone the remaster treatment. Nestled in Sony's latest State of Play event, the company announced that Days Gone Remastered is coming to PlayStation 5 and PC on April 25, 2025, [...]

Match Score: 85.29

Destination

2025-01-07

Engadget Podcast: We've survived two days of CES 2025

In this bonus episode, Cherlynn and Devindra discuss the latest innovations in robot vacuums, new AI PC hardware from AMD and Intel, and Dell's decision to nuke its PC brands in favor of Apple-es [...]

Match Score: 84.11

Destination

2025-04-23

Eli Lilly is stepping up its fight against copycat weight-loss drugs

In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss dr [...]

Match Score: 68.99

Destination

2025-05-13

Weight loss drugs are squeezing the food industry

The revolutionary GLP-1 class of weight loss drugs are racking up blockbuster sales at a pace rarely seen in the pharmaceutical industry. But the pharma industry’s gain is the food industry’s loss [...]

Match Score: 66.19

Destination

2025-08-05

OpenAI's first new open-weight LLMs in six years are here

For the first time since GPT-2 in 2019, OpenAI is releasing new open-weight large language models. It's a major milestone for a company that has increasingly been accused of forgoing its original [...]

Match Score: 58.30

Destination

2025-05-30

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]

Match Score: 57.28